FDA Approves Slow-Release Painkiller

Published November 21, 2014 at 1:35 PM EST

This product image provided by Purdue Pharma shows Hysingla, the first hard-to-abuse version of the painkiller hydrocodone. The Food and Drug Administration on Thursday, Nov. 20, 2014 approved Hysingla, a once-a-day tablet for patients with severe, round-the-clock pain that cannot be managed with other treatments. (Purdue Pharma via AP)

The FDA has approved a new opioid painkiller that releases over a 24-hour period, and is designed to reduce abuse by people chewing or smashing it into a powder for injection. However, the agency admits that abuse and overdose of the drug Hysingla is still possible.

Michael Regan of Bloomberg News spoke to Here & Now’s Jeremy Hobson about the new drug.

Guest

Michael Regan, editor for Bloomberg News. He tweets @Reganonymous.

Tags

Sick Season 2

Incarcerated people are some of the sickest people in our country. Many have chronic conditions such as diabetes or lung disease. And they’re far more likely to suffer from mental illness and addiction. On Season 2 of Sick, listen to stories of what goes wrong in corrections facilities — places meant to keep people healthy, but built to punish them.

Subscribe now